OUR TEAM
Innovation driven by people.
Our team is geared for building a next-generation drug discovery platform.
To revolutionize how we uncover therapies, we assembled the brightest and most ardent group of thinkers and doers with expertise spanning biology, computer science, structural chemistry, and more.
Team Of Experts
Our team has both broad and profound drug discovery experience.
LEADERSHIP
JOSEPH WU, MD, PHD
CO-FOUNDER
Dr. Joseph C. Wu, MD, PhD, is a Co-Founder of Greenstone Biosciences and a distinguished scientist specializing in cardiology.
JADE CHAO, MPH, JD
CO-FOUNDER/COO GENERAL COUNSEL
Jade is a dynamic and accomplished professional with a unique blend of expertise in health policy, law, big data, and biostatistics.
LIP-BU TAN
CHAIR, BOARD OF DIRECTORS
Lip-Bu Tan is a visionary entrepreneur and technology investor, renowned for his significant contributions to the semiconductor industry.
SCIENTIFIC ADVISORY BOARD
AXEL BRUNGER, PHD
SAB MEMBER
Professor Axel Brunger is a distinguished scientist widely recognized for his remarkable contributions to the field of structural biology and the elucidation of molecular mechanisms underlying synaptic transmission.
BRIAN KOBILKA, MD
SAB MEMBER
Professor Brian Kobilka is a renowned American scientist and Nobel laureate, celebrated for his groundbreaking contributions to the field of biochemistry and molecular biology.
JAMES ZOU, PHD
SAB MEMBER
Professor James Zou is an accomplished scientist and leading figure in the field of artificial intelligence and machine learning. Born with a passion for harnessing the power of data, Zou has made significant contributions to the areas of bioinformatics.
SCIENTISTS
MUKHTAR AHMED, PHD
DIRECTOR, PROJECT & PORTFOLIO STRATEGY
Mukhtar received his Ph.D. from the University of Toronto, Leslie Dan Faculty of Pharmacy, and studied G proteins. He did a postdoc at Vanderbilt University and served as research faculty before joining GSB.
HAO ZHANG, MD
SENIOR SCIENTIST
Dr. Zhang received his MD from Peking Union Medical College, Tsinghua University, where his work focused on improving the microenvironments of myocardial infarction.
JAMES JAHNG, PHD
SENIOR SCIENTIST
James is an accomplished scientist with a Ph.D. from the York University, Department of Biology, where he received exceptional training under the guidance of Professor Gary Sweeney.
JEREMY LEITZ, PHD
SENIOR SCIENTIST
Jeremy received his PhD in Neuroscience at the University of Texas Southwestern Medical Center, where he studied the molecular mechanisms of neurotransmission.
EVGENIOS NEOFYTOU, MD
SENIOR SCIENTIST
Dr. Neofytou received his MD from the Royal College of Surgeons in Dublin. After graduation, he joined Stanford as a Research Fellow studying cardiac regeneration using human pluripotent stem cell derived cardiomyocytes
SOUHRID MUKHERJEE, PHD
SENIOR SCIENTIST - AI AND COMPUTATIONAL BIOLOGY
Souhrid has worked extensively on computational biology and machine learning during his PhD at Vanderbilt University.
DAVID DOLIVO, PHD
PROJECT SCIENTIST
David received his PhD in Biology and Biotechnology at Worcester Polytechnic Institute, where he investigated relationships between molecular signaling and cellular phenotypes in order to augment regenerative therapies.
RABINDRA SHIVNARAINE, PHD
DIRECTOR, DRUG DISCOVERY
Rabindra (Robin) received his PhD from the Department of Pharmaceutical Sciences at the University of Toronto and his graduate work focused on the mechanism of allosteric modulators at G-protein coupled receptors (GPCRs).
HONIT PIPLANI, PHD
DIRECTOR, TRANSLATIONAL & CLINICAL SCIENCES
Honit received his Ph.D. from Panjab University, India followed by postdoctoral training at Stanford University and Cedars-Sinai Medical Center.
RESEARCHERS
CONSULTANTS
AUDREY JIA,
PHD
CONSULTANT
CMC Regulatory and GMP Professional
ex-FDA Drug Quality Reviewer
KE ZHANG, MD
PHD
CONSULTANT
DISCOVER OUR INNOVATIVE TECHNOLOGY
Be a part of an ambitious team with limitless potential
Do you want to be a part of an innovative company that helps patients? If you share our vision contact us.